General Information of the Compound
Compound ID
CP0011998
Compound Name
N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine
    Show/Hide
Synonyms
183322-45-4
4-Quinazolinamine, N-(3-bromo
4-[(3-BROMOPHENYL)AMINO]-6,7-DIMETHOXYQUINAZOLINE HYDROCHLORIDE
6,7-Dimethoxy-4-[N-(3-bromophenyl)amino]quinazoline hydrochloride
AG 1517
AG 1517 hydrochloride
AHJ252P69N
C16H15BrClN3O2
CHEMBL1204168
N-(3-Bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride
PD 153035 HYDROCHLORIDE
PD-153035
PD-153035 hydrochloride
PD153035 (Hydrochloride)
PD153035 HCl
PD153035 hydrochloride
PD153035.HCl
SU 5271
SU-5271 hydrochloride
Tyrphostin AG 1517
UNII-AHJ252P69N
ZM 252868
pd 153035
    Show/Hide
Structure
Formula
C16H14BrN3O2
Molecular Weight
360.211
Canonical SMILES
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC
    Show/Hide
InChI
InChI=1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
    Show/Hide
InChIKey
LSPANGZZENHZNJ-UHFFFAOYSA-N
Physicochemical Property
logP
4.1531
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
56.27
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 4705
SID: 14852461
ChEMBL ID
CHEMBL29197
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000036 MDCK-II Canis lupus familiaris (Dog)  2
1
IC50 = 1730 nM
   TI
   LI
   LO
   TS
2
IC50 = 2320 nM
   TI
   LI
   LO
   TS
Protein ID: PT01920, Cyclin-G-associated kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Kd = 29 nM
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  6
1
IC50 = 0.029 nM
   TI
   LI
   LO
   TS
2
IC50 = 4 nM
   TI
   LI
   LO
   TS
3
IC50 < 15 nM
   TI
   LI
   LO
   TS
4
IC50 = 30 nM
   TI
   LI
   LO
   TS
5
IC50 = 200 nM
   TI
   LI
   LO
   TS
6
IC50 = 230 nM
   TI
   LI
   LO
   TS
CL000254 DiFi Homo sapiens (Human)  1
1
IC50 = 70.79 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.029 nM
2 IC50 = 0.095 nM
3 IC50 = 2.6 nM
4 IC50 = 4 nM
5 IC50 = 5.3 nM
6 IC50 = 6 nM
7 IC50 = 25 nM
8 IC50 = 28 nM
9 IC50 = 63 nM
10 IC50 = 70 nM
11 IC50 = 200 nM
12 IC50 = 230 nM
13 IC50 > 100 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 12600 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PD-153035 )
Drug Name PD-153035
Indication
Psoriasis vulgaris
Discontinued in Phase 1
Target(s)
Epidermal growth factor receptor (EGFR)
Modulator